⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5725258 | 1.00 | — | — | |
| SCHEMBL7966536 | 0.74 | CHRNB2 (0.33) | — | |
| SCHEMBL7966539 | 0.74 | CHRNB2 (0.33) | — | |
| SCHEMBL7978641 | 0.73 | MEN1 (0.32) | — | |
| SCHEMBL7978643 | 0.73 | MEN1 (0.32) | — | |
| SCHEMBL7983341 | 0.70 | NPC1 (0.34) | — | |
| SCHEMBL7983339 | 0.70 | NPC1 (0.34) | — | |
| SCHEMBL7980246 | 0.67 | HTR1A (0.32) | — | |
| SCHEMBL5724890 | 0.67 | HTR1A (0.32) | — | |
| SCHEMBL5724985 | 0.64 | GAA (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160151316-A1 | METHOD OF TREATING TOURETTE'S DISORDER WITH GABA-AMINOTRANSFERASE INACTIVATORS | CATALYST PHARMACEUTICAL PARTNERS | 2016-06-02 | — | — | US | disclosed |
| US-9254274-B2 | Method of treating Tourette'S disorder with GABA-aminotransferase inactivators | CATALYST PHARMACEUTICAL PARTNERS, INC. (US) | 2016-02-09 | — | — | US | disclosed |
| US-20150196522-A1 | METHODS OF USING (1S,3S)-3-AMINO-4-DIFLUOROMETHYLENYL-1-CYCLOPENTANOIC ACID | NORTHWESTERN UNIVERSITY | 2015-07-16 | — | — | US | disclosed |
| US-8969413-B2 | Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid | CATALYST PHARMACEUTICAL PARTNERS (US) | 2015-03-03 | — | — | US | disclosed |
| EP-2806867-A1 | METHOD OF TREATING TOURETTE'S DISORDER WITH GABA-AMINOTRANSFERASE INACTIVATORS | Catalyst Pharmaceutical Partners, Inc. (US) | 2014-12-03 | — | — | EP | disclosed |
| US-20140336256-A1 | METHOD OF TREATING TOURETTE'S DISORDER WITH GABA-AMINOTRANSFERASE INACTIVATORS | CATALYST PHARMACEUTICAL PARTNERS | 2014-11-13 | — | — | US | disclosed |
| WO-2013112363-A1 | METHOD OF TREATING TOURETTE'S DISORDER WITH GABA-AMINOTRANSFERASE INACTIVATORS | CATALYST PHARMACEUTICAL PARTNERS (US) | 2013-08-01 | — | — | WO | disclosed |
| US-20130041028-A1 | METHODS OF USING (1S,3S)-3-AMINO-4-DIFLUOROMETHYLENYL-1-CYCLOPENTANOIC ACID | NORTHWESTERN UNIVERSITY (US) | 2013-02-14 | — | — | US | disclosed |
| EP-2542234-A2 | METHODS OF USING (1S, 3S) -3-AMINO-4-DIFLUOROMETHYLENYL-1-CYCLOPENTANOIC ACID | North Western University (US) | 2013-01-09 | — | — | EP | disclosed |
| WO-2011106692-A2 | METHODS OF USING (1S, 3S) -3-AMINO-4-DIFLUOROMETHYLENYL-1-CYCLOPENTANOIC ACID | NORTHWESTERN UNIVERSITY (US) | 2011-09-01 | — | — | WO | disclosed |
| EP-0812318-B1 | 4-AMINOTETRAHYDROBENZISOXAZOLE OR -ISOTHIAZOLE COMPOUNDS | LUNDBECK & CO AS H (DK) | 2006-02-08 | — | — | EP | disclosed |
| US-6174909-B1 | FOR TREATING ANALGESIA, PSYCHOSIS, CONVULSIONS, EPILEPSY, ANXIETY, MUSCULAR AND MOVEMENT DISORDERS, SPASTIC DISORDERS OR SYMPTOMS OF HUNTINGTON'S OR PARKINSONS DISEASE | H. LUNDBECK A/S (DK) | 2001-01-16 | — | — | US | disclosed |
| US-5998613-A | PSYCHOLOGICAL DISORDERS; ANALGESICS; ANTICONVULSANTS | H. LUNDBECK A/S (DK) | 1999-12-07 | — | — | US | disclosed |
| EP-0812318-A1 | 4-AMINOTETRAHYDROBENZISOXAZOLE OR -ISOTHIAZOLE COMPOUNDS | H. LUNDBECK A/S (DK) | 1997-12-17 | — | — | EP | disclosed |
| WO-1996026929-A1 | 4-AMINOTETRAHYDROBENZISOXAZOLE OR -ISOTHIAZOLE COMPOUNDS | H. LUNDBECK A/S (DK) | 1996-09-06 | — | — | WO | disclosed |